Entasis Therapeutics Holdings OverviewEntasis Therapeutics Holdings Other Income Expense Net
Other Income/Expense Net for ETTX.
Quarterly Other Income/Expense
-$10000.00
↓ 100.51% YoY
As of Mar 31, 2022
Annual Other Income/Expense (TTM)
$2.47M
↓ 55.72% YoY
Trailing 12 months ending Mar 31, 2022